Skip to main content
. 2002 Mar;160(3):893–903. doi: 10.1016/S0002-9440(10)64912-7

Figure 7.

Figure 7.

Univariate survival analysis (Kaplan-Meier) of all 86 patients with invasive ovarian carcinomas. A: Patients with tumors negative for COX-2 have an increased median survival time (52.47 months, n = 50) compared to patients with tumors positive for COX-2 (30.40 months, n = 36) (log rank test; P = 0.04). B: Patients <60 years of age have a longer median survival time (52.77) compared to patients >60 years of age (30.10 months, P < 0.02). C: For patients younger than 60 years of age with tumors negative for COX-2 the median survival time is not reached during the follow-up period of 110 months, whereas patients in the same age group with tumors positive for COX-2 have a median survival time of 34.63 months (P < 0.004). D: In contrast, for patients older than 60 years of age there are no differences in median survival time between patients with tumors negative for COX-2 (30.10 months) and tumors positive for COX-2 (36.13 months, P = 0.97).